| SC 13D/A | 2024-03-04 | Innoviva, Inc. | Armata Pharmaceuticals, Inc. | 64,178,259 | 85.3% | EDGAR |
| SC 13D/A | 2023-07-11 | Innoviva, Inc. | Armata Pharmaceuticals, Inc. | 64,178,259 | 85.3% | EDGAR |
| SC 13D/A | 2023-01-10 | Innoviva, Inc. | Armata Pharmaceuticals, Inc. | 64,178,259 | 85.3% | EDGAR |
| SC 13D/A | 2022-04-01 | Innoviva, Inc. | Armata Pharmaceuticals, Inc. | 44,441,416 | 80.1% | EDGAR |
| SC 13D/A | 2022-02-11 | Innoviva, Inc. | Armata Pharmaceuticals, Inc. | 36,363,604 | 76.7% | EDGAR |
| SC 13D/A | 2021-11-01 | Innoviva, Inc. | Armata Pharmaceuticals, Inc. | 30,941,416 | 73.8% | EDGAR |
| SC 13D/A | 2021-04-05 | Innoviva, Inc. | Armata Pharmaceuticals, Inc. | - | - | EDGAR |
| SC 13D/A | 2021-03-17 | Innoviva, Inc. | Armata Pharmaceuticals, Inc. | 29,729,294 | 74.7% | EDGAR |
| SC 13D/A | 2021-01-27 | Innoviva, Inc. | Armata Pharmaceuticals, Inc. | 21,157,424 | 68.0% | EDGAR |
| SC 13D/A | 2020-03-31 | Innoviva, Inc. | Armata Pharmaceuticals, Inc. | 17,421,600 | 63.7% | EDGAR |
| SC 13D | 2020-02-14 | Innoviva, Inc. | Armata Pharmaceuticals, Inc. | 1,986,278 | 16.7% | EDGAR |
| SC 13G | 2019-11-12 | SYNTHETIC GENOMICS INC | Armata Pharmaceuticals, Inc. | 516,976 | 5.2% | EDGAR |
| SC 13D | 2019-05-21 | Delta Dental of Wisconsin, Inc. | Armata Pharmaceuticals, Inc. | 2,107,675 | 21.2% | EDGAR |
| SC 13G | 2019-05-21 | Corvesta, Inc. | Armata Pharmaceuticals, Inc. | 633,944 | 6.4% | EDGAR |
| SC 13G | 2019-05-17 | Delta Dental Plan of Michigan, Inc. | Armata Pharmaceuticals, Inc. | 1,265,802 | 12.7% | EDGAR |
| SC 13G | 2019-05-10 | DELTA DENTAL OF CALIFORNIA | Armata Pharmaceuticals, Inc. | 990,643 | 10.0% | EDGAR |
| SC 13G/A | 2019-01-30 | Hudson Bay Capital Management LP | AmpliPhi Biosciences Corp | 498,890 | 5.0% | EDGAR |
| SC 13G/A | 2019-01-10 | Empery Asset Management, LP | AmpliPhi Biosciences Corp | 1,316,116 | 3.9% | EDGAR |
| SC 13G/A | 2019-01-04 | SABBY MANAGEMENT, LLC | AmpliPhi Biosciences Corp | 467,730 | 1.4% | EDGAR |
| SC 13G | 2018-03-29 | ARMISTICE CAPITAL, LLC | AmpliPhi Biosciences Corp | 0 | 0.0% | EDGAR |